Land: USA
Sprog: engelsk
Kilde: NLM (National Library of Medicine)
FERRIC SUBSULFATE (UNII: 3QJ8WS6V8H) (FERRIC CATION - UNII:91O4LML611)
CooperSurgical, Inc.
TOPICAL
PRESCRIPTION DRUG
AstrinGyn® is a styptic agent used for achieving local hemostasis. In punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.1 One method for applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edges of the wound and stretching the skin. The wound is then wiped with gauze, the ferric subsulfate solution applied, and the tension maintained for approximately 15 seconds.2
8 gm single-use glass bottles.
unapproved drug other
FERRIC SUBSULFATE- FERRIC SUBSULFATE SOLUTION COOPERSURGICAL, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this_ _labeling has not been approved by FDA. For further information about unapproved_ _drugs, click here._ ---------- ASTRINGYN ASTRINGYN® (FERRIC SUBSULFATE, AQUEOUS) REF 6065 CONTENTS Ferric subsulfate 259mg/g [0.0638gm Fe / ]. Preserved with benzalkonium chloride 0.005%. Povidone USP 23.2%. Glycerin USP 13.3%. Purified Water USP. DESCRIPTION AstrinGyn® (Ferric Subsulfate, Aqueous). HOW SUPPLIED 8 gm single-use glass bottles. ACTIONS & USES AstrinGyn® is a styptic agent used for achieving local hemostasis. In punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds. One method for applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edges of the wound and stretching the skin. The wound is then wiped with gauze, the ferric subsulfate solution applied, and the tension maintained for approximately 15 seconds. WARNINGS FOR EXTERNAL USE ONLY. Should inadvertent ocular administration occur, the eye(s) should be washed immediately with large amounts of water or normal saline, occasionally lifting the upper and lower lids until no evidence of solution remains (approximately 15-20 minutes). PRECAUTIONS As with all iron solutions applied to dermal surfaces denuded of epithelium or to mucous 3+ ml 1 2 membranes, topical application of AstrinGyn® (ferric subsulfate) may result in hyperpigmentation (“tattooing”). Microscopically, this hyperpigmentation may be observed as ferrugination of collagen fibers and fibrin. In one study of uterine cervical tissue, ferric subsulfate solution penetrated denuded mucosa and produced coagulation necrosis to a maximum depth of 0.6 mm. IN AN IN VITRO STUDY, FERRIC SUBSULFATE SOLUTION PRODUCED A RADIOPACITY WITH A DENSITY INTERMEDIATE BETWEEN THAT OF WATER/TISSUE AND CALCIUM. Should a re-biopsy of the same lesion be required, pathologists a Læs hele dokumentet